ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities

ClinicalTrials.gov ID: NCT06794996

Public ClinicalTrials.gov record NCT06794996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 9:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Open-label Study to Evaluate the Efficacy and Safety of Inaxaplin in Subjects With Proteinuric APOL1-mediated Kidney Disease With or Without Comorbidities That May Independently Contribute to Chronic Kidney Disease

Study identification

NCT ID
NCT06794996
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vertex Pharmaceuticals Incorporated
Industry
Enrollment
42 participants

Conditions and interventions

Interventions

  • Inaxaplin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 67 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 3, 2025
Primary completion
Dec 29, 2026
Completion
Dec 29, 2026
Last update posted
May 4, 2026

2025 – 2026

United States locations

U.S. sites
35
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Nephrology Consultants, LLC Huntsville Alabama 35805
Foundation for Sickle Cell Disease Research, LLC Hollywood Florida 33023
South Florida Research Institute Lauderdale Lakes Florida 33313
Schiff Center for Liver Diseases Miami Florida 33136
CTR Oakwater, LLC Orlando Florida 32806
Renal Associates, LLC Columbus Georgia 31904
Georgia Nephrology - Decatur Decatur Georgia 30030
Javara Inc./Privia Medical Group Georgia, LLC - Fayetteville Fayetteville Georgia 30214
Georgia Nephrology Lawrenceville Georgia 30046
Javara Inc. /Privia Medical Group Georgia, LLC - Savannah Savannah Georgia 31406
Renal Associates of Baton Rouge Baton Rouge Louisiana 70808
LCMC Health Metairie Louisiana 70006
Ochsner Medical Center - New Orleans - Nephrology New Orleans Louisiana 70121
Northwest Louisiana Nephrology, LLC - Shreveport Shreveport Louisiana 71101
Javara Inc./Privia Medical Group, LLC MidAtlantic-Silver Spring, MD Silver Spring Maryland 20901
Nephrology Associates, P.C. Columbus Mississippi 39705
Nephrology and Hypertension Associates, LTD Tupelo Mississippi 38801
DaVita Kidney Care - Las Vegas Las Vegas Nevada 89107
Saint Michael's Medical Center - Peter Ho Memorial Clinic Newark New Jersey 07102
Rutgers Doctors Office Center Newark New Jersey 07103
Scott Research, Inc. Laurelton New York 11413
NYC Health + Hospital/Harlem New York New York 10037
North Carolina Nephrology P.A. - Cary Office Cary North Carolina 27511
UNC Clinical and Translational Research Center Chapel Hill North Carolina 27599-7155
Duke University Hospital - Children's Health Center Durham North Carolina 27710
Eastern Nephrology Associates - New Bern Office New Bern North Carolina 28562
Lewis Katz School of Medicine at Temple University - Section of Nephrology Philadelphia Pennsylvania 19140
Columbia Nephrology Associates, PA Columbia South Carolina 29203
Carolina Nephrology, PA Spartanburg South Carolina 29306
Dallas Renal Group - 2 Dallas Texas 75230
Dallas Renal Group - 1 Dallas Texas 75237
Dallas Nephrology Associates - Dallas Landry Office Dallas Texas 75246
UTSW Medical Center - Nephrology Dallas Texas 75390
Prolato Clinical Research Center Houston Texas 77054
Tks Research, P.L.L.C. Norfolk Virginia 23504

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06794996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06794996 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →